Copyright
©The Author(s) 2016.
World J Virol. Feb 12, 2016; 5(1): 14-22
Published online Feb 12, 2016. doi: 10.5501/wjv.v5.i1.14
Published online Feb 12, 2016. doi: 10.5501/wjv.v5.i1.14
Study period | No. of volunteers | No. HCV seropositive |
2008 | 35859 | 937 |
2009 | 65330 | 1713 |
2010 | 254177 | 3958 |
2011 | 173873 | 3060 |
2012 | 260139 | 4480 |
2013 | 218836 | 3749 |
Total | 1008214 | 17897 |
Yr | Prevalence (%) | OR | 95%CI | Minimum | Maximum | |
Lower | Upper | |||||
2008 | 2.6 | 1.4 | 2.3 | 2.8 | 2.0 | 3.2 |
2009 | 2.6 | 1.4 | 1.7 | 3.4 | 1.1 | 4.1 |
2010 | 1.5 | 0.8 | 1.3 | 1.6 | 0.9 | 2.1 |
2011 | 1.7 | 0.7 | 1.3 | 2.0 | 0.8 | 2.8 |
2012 | 1.7 | 1.1 | 0.8 | 2.6 | 0.6 | 2.9 |
2013 | 1.7 | 1.1 | 0.9 | 2.5 | 0.7 | 2.7 |
Total | 1.8 | 1.1 | 1.4 | 2.5 | 1.0 | 3.0 |
- Citation: Daw MA, Shabash A, El-Bouzedi A, Dau AA, Habas M, Libyan Study Group of Hepatitis and HIV. Modelling the prevalence of hepatitis C virus amongst blood donors in Libya: An investigation of providing a preventive strategy. World J Virol 2016; 5(1): 14-22
- URL: https://www.wjgnet.com/2220-3249/full/v5/i1/14.htm
- DOI: https://dx.doi.org/10.5501/wjv.v5.i1.14